GenAI Mental Health Devices Market Size, Share, and Trends 2026 to 2035

GenAI Mental Health Devices Market (By Product Type: Wearable Devices: 35%, Mobile & App-Integrated Devices: 25%, Portable Diagnostic Devices: 15%, Stationary Clinical Devices: 8%; By Deployment Type: Home/Personal Use: 50%, Clinical/Hospital/Therapy Centers: 30%, Corporate/Workplace Wellness Programs: 12%; By Distribution Channel: Online/E-commerce Platforms: 40%, Hospital & Clinical Channels: 15%, Direct-to-Consumer Subscriptions/Programs: 5%; By Technology Type: AI-Powered Cognitive Behavioral Therapy Devices: 40%, Neurofeedback & Brain Stimulation Devices: 25%, Sleep & Stress Monitoring Devices: 15%, Virtual/Augmented Reality Therapeutic Devices: 12%; By End-User/Consumer Type: Adults: 60%, Seniors: 15%, Adolescents/Teenagers: 12%, Children: 8%, Other/Institutional Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : 21 Nov 2025  |  Report Code : 7130  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on GenAI Mental Health Devices Market and their Offerings Market 

5.1. COVID-19 Landscape: GenAI Mental Health Devices Market and their Offerings Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global GenAI Mental Health Devices Market and their Offerings Market, By Product Type

8.1. GenAI Mental Health Devices Market and their Offerings Market Revenue and Volume, by Product Type

8.1.1. Wearable Devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Mobile & App-Integrated Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Portable Diagnostic Devices

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. VR/AR Therapeutic Devices

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Stationary Clinical Devices

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global GenAI Mental Health Devices Market and their Offerings Market, By Deployment Type

9.1. GenAI Mental Health Devices Market and their Offerings Market Revenue and Volume, by Deployment Type

9.1.1. Home/Personal Use

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Clinical / Hospital / Therapy Centers

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Corporate / Workplace Wellness Programs

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Deployments

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global GenAI Mental Health Devices Market and their Offerings Market, By Distribution Channel 

10.1. GenAI Mental Health Devices Market and their Offerings Market Revenue and Volume, by Distribution Channel

10.1.1. Online / E-commerce Platforms: 40%

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Retail Stores / Electronics & Healthcare Outlets

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Hospital & Clinical Channels: 15%

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Direct-to-Consumer Subscriptions / Programs: 5%

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Other Channels: 5%

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global GenAI Mental Health Devices Market and their Offerings Market, By Technology Type

11.1. GenAI Mental Health Devices Market and their Offerings Market Revenue and Volume, by Technology Type

11.1.1. AI-Powered Cognitive Behavioral Therapy (CBT) Devices: 40%

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Neurofeedback & Brain Stimulation Devices: 25%

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Sleep & Stress Monitoring Devices: 15%

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Virtual / Augmented Reality Therapeutic Devices: 12%

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Other Technology Types: 8%

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global GenAI Mental Health Devices Market and their Offerings Market, By End-User / Consumer Type

12.1. GenAI Mental Health Devices Market and their Offerings Market Revenue and Volume, by End-User / Consumer Type

12.1.1. Adults (18–60): 60% (Dominating)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Seniors (60+): 15%

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Adolescents / Teenagers: 12%

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Children (under 12): 8%

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Other / Institutional Users

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global GenAI Mental Health Devices Market and their Offerings Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Deployment Type

13.1.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.4. Market Revenue and Volume Forecast, by Technology Type

13.1.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Deployment Type

13.1.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6.4. Market Revenue and Volume Forecast, by Technology Type

13.1.6.5. Market Revenue and Volume Forecast, by End-User / Consumer Type  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Deployment Type

13.1.7.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7.4. Market Revenue and Volume Forecast, by Technology Type

13.1.7.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Deployment Type

13.2.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.4. Market Revenue and Volume Forecast, by Technology Type  

13.2.5. Market Revenue and Volume Forecast, by End-User / Consumer Type  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Deployment Type

13.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.7. Market Revenue and Volume Forecast, by Technology Type  

13.2.8. Market Revenue and Volume Forecast, by End-User / Consumer Type  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Deployment Type

13.2.9.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.10. Market Revenue and Volume Forecast, by Technology Type

13.2.11. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Deployment Type

13.2.12.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12.4. Market Revenue and Volume Forecast, by Technology Type

13.2.13. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Deployment Type

13.2.14.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14.4. Market Revenue and Volume Forecast, by Technology Type

13.2.15. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Deployment Type

13.3.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.4. Market Revenue and Volume Forecast, by Technology Type

13.3.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Deployment Type

13.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6.4. Market Revenue and Volume Forecast, by Technology Type

13.3.7. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Deployment Type

13.3.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8.4. Market Revenue and Volume Forecast, by Technology Type

13.3.9. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Deployment Type

13.3.10.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10.4. Market Revenue and Volume Forecast, by Technology Type

13.3.10.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Deployment Type

13.3.11.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11.4. Market Revenue and Volume Forecast, by Technology Type

13.3.11.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Deployment Type

13.4.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.4. Market Revenue and Volume Forecast, by Technology Type

13.4.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Deployment Type

13.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6.4. Market Revenue and Volume Forecast, by Technology Type

13.4.7. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Deployment Type

13.4.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8.4. Market Revenue and Volume Forecast, by Technology Type

13.4.9. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Deployment Type

13.4.10.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10.4. Market Revenue and Volume Forecast, by Technology Type

13.4.10.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Deployment Type

13.4.11.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11.4. Market Revenue and Volume Forecast, by Technology Type

13.4.11.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Deployment Type

13.5.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.4. Market Revenue and Volume Forecast, by Technology Type

13.5.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Deployment Type

13.5.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6.4. Market Revenue and Volume Forecast, by Technology Type

13.5.7. Market Revenue and Volume Forecast, by End-User / Consumer Type

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Deployment Type

13.5.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8.4. Market Revenue and Volume Forecast, by Technology Type

13.5.8.5. Market Revenue and Volume Forecast, by End-User / Consumer Type

Chapter 14. Company Profiles

14.1. Woebot Health

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Wysa

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Koa Health

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Headspace Health

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Ginger

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Talkspace

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. BetterHelp

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Pear Therapeutics

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Mindstrong Health

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Limbic AI

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The major players in the genAI mental health devices market include Limbic AI, Mindstrong Health,Pear Therapeutics, BetterHelp, Talkspace, Ginger, Headspace Health, Koa Health, Wysa, Woebot Health, Spring Health, Lyra Health, Quartet Health, Happify Health, and Flow Neuroscience.

Answer : The driving factors of the genAI mental health devices market are the rising demand for personalized support, improved diagnostic capabilities, and broader integration of AI-powered therapeutic tools across diverse healthcare settings.

Answer : North America region will lead the global genAI mental health devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client